Heparin compared with normal saline to maintain patency of permanent double lumen hemodialysis catheters: A randomized controlled trial

Beigi, Ali Akbar; HadiZadeh, Mirhadi Seyed; Salimi, Fereshteh; Ghaheri, Hafez

Heparin compared with normal saline to maintain patency of permanent double lumen hemodialysis catheters: A randomized controlled trial

Authors

Department of Vascular Surgery, Isfahan University of Medical Sciences, Isfahan, Iran

Abstract

Background: Heparin has long been used to prevent thrombosis in the permanent central venous hemodialysis catheters (PermCath). Other alternatives for heparin with fewer side-effects have recently been considered. We compared normal saline (0.9%) with heparin for flushing PermCath with regards to catheter patency and prevention of heparin complications.
Materials and Methods: Chronic kidney disease patients who were candidate of PermCath placement were randomly assigned into two groups of heparin and saline. In the heparin group, the PermCath was flushed with heparin (1000 IU), and in the saline group, it was flushed with saline 0.9%. Patients were followed for 24 hours, and outcomes included catheter thrombosis, maneuver needed to maintain catheter patency, and bleeding from catheter site.
Results: Ninety six patients were included (age = 63.1 ± 11.2 years, 54.2% male). No one experienced catheter thrombosis. Two patient (4.2%) in the heparin and three ones (6.1%) in the saline group required catheter manipulation (P = 0.520). Four patients (8.5%) in the heparin and three ones (6.1%) in the saline group experienced bleeding (P = 0.476); differences between heparin and saline groups in the amount of bleeding (225.0 ± 62.4 vs. 200.0 ± 113.5 cc, P = 0.721) and bleeding time (6.5 ± 1.2 vs. 5.3 ± 1.5 min, P = 0.322) were not significant. In the heparin group, no significant increase was observed in PTT over time; baseline 30.9 ± 3.4, 12 h 31.8 ± 3.4, 24 h 31.2 ± 6.6 (P = 0.628).
Conclusions: Flushing PermCath with normal saline 0.9% is as effective as heparin in maintaining patency of the catheter, while it may reduce the risks associated with heparin.

Keywords

References

1.	NKF-DOQI clinical practice guidelines for vascular access. National Kidney Foundation-Dialysis Outcomes Quality Initiative. Am J Kidney Dis 1997;30:S150-91. [PUBMED]
2.	Trerotola SO. Hemodialysis catheter placement and management. Radiology 2000;215:651-8. [PUBMED]
3.	Liangos O, Gul A, Madias NE, Jaber BL. Long-term management of the tunneled venous catheter. Semin Dial 2006;19:158-64.
4.	Moran JE, Ash SR. Locking solutions for hemodialysis catheters; heparin and citrate-a position paper by ASDIN. Semin Dial 2008;21:490-2.
5.	Dreyer G, Lawton P, Jose M. Heparin leak from a hemodialysis catheter causing major bleeding, ultimately leading to transplant rejection and death. Hemodial Int 2008;12:431-3.
6.	Thomson PC, Morris ST, Mactier RA. The effect of heparinized catheter lock solutions on systemic anticoagulation in hemodialysis patients. Clin Nephrol 2011;75:212-7.
7.	Yevzlin AS, Sanchez RJ, Hiatt JG, Washington MH, Wakeen M, Hofmann RM, et al. Concentrated heparin lock is associated with major bleeding complications after tunneled hemodialysis catheter placement. Semin Dial 2007;20:351-4.
8.	Buturovic J, Ponikvar R, Kandus A, Boh M, Klinkmann J, Ivanovich P. Filling hemodialysis catheters in the interdialytic period: Heparin versus citrate versus polygeline: A prospective randomized study. Artif Organs 1998;22:945-7.
9.	Del CM, Grane N, Llavore M, Quintana S. Heparinized solution vs. saline solution in the maintenance of arterial catheters: A double blind randomized clinical trial. Intensive Care Med 2008;34:339-43.
10.	Moran J, Sun S, Khababa I, Pedan A, Doss S, Schiller B. A randomized trial comparing gentamicin/citrate and heparin locks for central venous catheters in maintenance hemodialysis patients. Am J Kidney Dis 2012;59:102-7.
11.	Hughes K, Chang YC, Sedrak J, Torres A. A clinically practical way to estimate surgical blood loss. Dermatol Online J 2007;13:17.
12.	Pumarola C, Casademont MR, Colomer PM, Cordon BC, Sabench CS, Felez VM, et al. Comparative study of maintenance of patency of triple lumen central venous catheter. Enferm Intensiva 2007;18:25-35.
13.	Kaneko Y, Iwano M, Yoshida H, Kosuge M, Ito S, Narita I, et al. Natural saline-flush is sufficient to maintain patency of immobilized-urokinase double-lumen catheter used to provide temporary blood access for hemodialysis. Blood Purif 2004;22:473-9.
14.	Rabe C, Gramann T, Sons X, Berna M, Gonzalez-Carmona MA, Klehr HU, et al. Keeping central venous lines open: A prospective comparison of heparin, vitamin C and sodium chloride sealing solutions in medical patients. Intensive Care Med 2002;28:1172-6.

Advanced Biomedical Research